Equities analysts forecast that Aetna Inc (NYSE:AET) will announce earnings of $3.00 per share for the current quarter, Zacks reports. Seven analysts have provided estimates for Aetna’s earnings. The highest EPS estimate is $3.20 and the lowest is $2.82. Aetna posted earnings of $2.71 per share in the same quarter last year, which suggests a positive year-over-year growth rate of 10.7%. The company is scheduled to report its next earnings report before the market opens on Tuesday, May 1st.
According to Zacks, analysts expect that Aetna will report full-year earnings of $11.02 per share for the current fiscal year, with EPS estimates ranging from $10.65 to $11.50. For the next financial year, analysts forecast that the company will post earnings of $12.21 per share, with EPS estimates ranging from $11.90 to $12.70. Zacks’ EPS averages are an average based on a survey of research firms that that provide coverage for Aetna.
Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, January 30th. The company reported $1.25 EPS for the quarter, topping the Zacks’ consensus estimate of $1.18 by $0.07. The business had revenue of $14.74 billion during the quarter, compared to the consensus estimate of $14.79 billion. Aetna had a return on equity of 21.50% and a net margin of 3.15%. The company’s revenue for the quarter was down 6.2% compared to the same quarter last year. During the same period last year, the firm earned $0.08 earnings per share.
A number of equities analysts recently commented on AET shares. Credit Suisse Group lifted their price target on Aetna from $200.00 to $208.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 31st. Jefferies Group reiterated a “hold” rating and issued a $205.00 price target on shares of Aetna in a research note on Wednesday, January 31st. Cowen reiterated a “buy” rating and issued a $212.00 price target on shares of Aetna in a research note on Tuesday, January 30th. Piper Jaffray reissued a “buy” rating and issued a $212.00 target price on shares of Aetna in a report on Tuesday, January 30th. Finally, Citigroup cut shares of Aetna from a “buy” rating to a “neutral” rating and raised their target price for the stock from $187.89 to $212.00 in a report on Wednesday, January 31st. Nine investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $189.50.
NYSE:AET opened at $172.93 on Wednesday. The stock has a market capitalization of $56,652.60, a P/E ratio of 17.54, a PEG ratio of 1.40 and a beta of 0.67. Aetna has a one year low of $127.86 and a one year high of $194.40. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.65 and a quick ratio of 0.65.
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Thursday, April 12th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, April 11th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.16%. Aetna’s dividend payout ratio (DPR) is presently 20.28%.
Several institutional investors and hedge funds have recently added to or reduced their stakes in AET. Focused Wealth Management Inc raised its holdings in shares of Aetna by 84.5% during the fourth quarter. Focused Wealth Management Inc now owns 655 shares of the company’s stock valued at $118,000 after buying an additional 300 shares during the last quarter. Cerebellum GP LLC bought a new stake in shares of Aetna during the fourth quarter valued at approximately $125,000. James Hambro & Partners bought a new stake in shares of Aetna during the fourth quarter valued at approximately $158,000. Harel Insurance Investments & Financial Services Ltd. bought a new stake in shares of Aetna during the fourth quarter valued at approximately $180,000. Finally, Signature Estate & Investment Advisors LLC bought a new stake in shares of Aetna during the fourth quarter valued at approximately $182,000. 87.25% of the stock is currently owned by institutional investors.
WARNING: This piece of content was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.dispatchtribunal.com/2018/04/14/brokerages-expect-aetna-inc-aet-will-post-earnings-of-3-00-per-share.html.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Get a free copy of the Zacks research report on Aetna (AET)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.